Butterfly Network

Butterfly Network, Inc. is an American digital health company headquartered at 1600 District Avenue, Burlington, Massachusetts, and incorporated in Delaware. Legacy Butterfly was founded in 2011 by Jonathan M. Rothberg. In 2020, Longview Acquisition Corp. (a SPAC incorporated in Delaware on February 4, 2020) was formed to merge with Butterfly. The Business Combination closed on February 12, 2021, with Longview Acquisition Corp. renamed Butterfly Network, Inc. The company is listed on the NYSE under the ticker BFLY. Its key technology is Ultrasound-on-Chip™ - a semiconductor CMOS device replacing multiple traditional piezoelectric probes with a single handheld device capable of whole-body imaging. Main products: Butterfly iQ+ (approx. USD 2,700), Butterfly iQ3 (approx. USD 3,900, powered by the P4.3 chip), iQ+ Bladder, iQ3 Vet, and Butterfly Move (POCUS cart). A Butterfly subscription is required for full functionality (Basic Technology ~USD 300/year, Advanced Technology ~USD 420/year). The company also offers Compass AI™ enterprise software. Products are distributed in over 30 countries, and devices are used in over 100 countries. As of January 2026, Butterfly employed approximately 220 people (approximately 180 in the U.S., approximately 40 outside the U.S.). CEO and Chairman of the Board: Joseph DeVivo (since April 2023; full CEO role since January 2024). Founder Jonathan M. Rothberg holds 100% of Class B shares, representing approximately 71% of voting power. Butterfly held approximately 665 issued patents and pending patent applications in the U.S., EU, and UK as of February 2026.